Award
NIH Reporter #5K00CA284289-05
Investigating retrotransposon activity-mediated EMT plasticity and immune cell dysfunction in pancreatic ductal adenocarcinoma
Recipient
Massachusetts General Hospital, Boston, MA, United States
Award Amount
$111,938.00
Ceiling
$111,938.00
Awarded
August 27, 2026
Identifier
5K00CA284289-05
Research to understand how chromatin regulation and immune response contribute to tumor heterogeneity and progression in lung and pancreatic cancers, using genomic and immunological methods.
Description
This project aims to elucidate mechanisms of chromatin regulation and immune evasion in lung and pancreatic cancers, with a focus on tumor heterogeneity and progression. It involves advanced genomic and immunological techniques, including chromatin conformation assays and multi-omics analyses.